FDA: Osteoporosis Drug Reclast Ups Kidney Failure Risk

FDA: Osteoporosis Drug Reclast Raises Kidney Failure Risk Agency Says Kidney Failure Is a Rare but Serious Risk of Reclast WebMD Health News By Matt McMillen Reviewed by Laura J....

Click here to read the full story.

Post a Comment
 

 
Comments
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.